Literature DB >> 16553566

Treatment of pneumonia in elderly patients.

Malina Schmidt-Ioanas1, Hartmut Lode.   

Abstract

Pneumonia represents the leading cause of infection-related death and the fifth cause of overall mortality, in the elderly. Several risk factors for acquiring pneumonia in older age have been reported, such as alcoholism, lung and heart diseases, nursing home residence and swallowing disorders. The clinical characteristics of pneumonia in the elderly differ substantially compared with younger patients, and the severity of the disease is strongly associated with increased age and age-related comorbidities. Streptococcus pneumoniae is the leading pathogen responsible for pneumonia in elderly; enteric Gram-negative rods should be considered in nursing-home-acquired pneumonia, as well anaerobes in patients with aspiration pneumonia. Antimicrobial therapy should take into account the most recent guidelines, which are briefly presented in this review. A special consideration should be given to the preventive measures, including vaccination, oral care and nutrition.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16553566     DOI: 10.1517/14656566.7.5.499

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN: 1465-6566            Impact factor:   3.889


  4 in total

1.  Predictors of pneumococcal vaccination among older adults with pneumonia: findings from the Community Acquired Pneumonia Impact Study.

Authors:  Paul Krueger; Oona St Amant; Mark Loeb
Journal:  BMC Geriatr       Date:  2010-06-30       Impact factor: 3.921

2.  A cross-sectional study to investigate pneumococcal vaccination in the elderly in a low income county: patient knowledge, awareness, and attitudes of vaccination and prevalence rates by socioeconomic status.

Authors:  Shoukat Ali Baig; Maroof Hassan; Syed Mustajab Ahmed; Wardah Moazzam; Ailya Inayat
Journal:  Hum Vaccin Immunother       Date:  2014-02-04       Impact factor: 3.452

3.  Structure of a complex of human lactoferrin N-lobe with pneumococcal surface protein a provides insight into microbial defense mechanism.

Authors:  Olga Senkovich; William J Cook; Shaper Mirza; Susan K Hollingshead; Irina I Protasevich; David E Briles; Debasish Chattopadhyay
Journal:  J Mol Biol       Date:  2007-05-10       Impact factor: 5.469

Review 4.  A brief review of moxifloxacin in the treatment of elderly patients with community-acquired pneumonia (CAP).

Authors:  Anna M Ferrara
Journal:  Clin Interv Aging       Date:  2007       Impact factor: 4.458

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.